BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014

Size: px
Start display at page:

Download "BULLETIN # 78. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2014"

Transcription

1 BULLETIN # 78 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability Formulary Regulation will be available on the Manitoba Health website on the effective date of July 17, 2014 Bulletin 78 is currently available for download: Inside This Issue Part 1 Additions Page 1-2 Part 2 Additions Page 2-3 Part 3 Additions Page 3-4 New Interchangeable Categories Page 4-5 New Interchangeable Products Page 5-9 Product Deletions Page 9-10 Category Deletions Page Interchangeable Product Price Changes Page Discontinued Products Page 15 Manufacturer Updates Page 15-16

2 Part 1 Additions Bulletin #78 DIN TRADE NAME GENERIC STRENGTH FORM MFR* Abbott-Citalopram citalopram 20 mg ABB mg Abbott-Clopidogrel clopidogrel 75 mg ABB Abbott-Topiramate topiramate 25 mg 100 mg 200 mg Acuvail ketorolac 0.45% Ophthalmic ALL Anastrozole anastrozole 1 mg ACH Apo-Exemestane exemestane 25 mg APX Apo-Temozolomide temozolomide 5 mg 20 mg 100 mg 140 mg 180 mg Auro-Mirtazapine mirtazapine 15 mg 30 mg Auro-Valsartan HCT valsartan/hctz 80/12.5 mg 160/12.5 mg 160/25 mg 320/12.5 mg 320/25 mg Bionime GE Epuris isotretinoin 20 mg 30 mg 40 mg Capsule Blood Glucose Test Strip Capsule Fluoxetine fluoxetine Capsule ACH 20 mg Haloperidol haloperidol 5 mg/ml Injection OMA Jamp-Irbesartan Jamp-Irbesartan/HCTZ irbesartan irbesartan/hctz 75 mg 150 mg 300 mg 150/12.5 mg 300/12.5 mg 300/25 mg Jamp-Omeprazole DR omeprazole 20 mg JPC Jamp-Pantoprazole pantoprazole 40 mg JPC Jamp-Tobramycin tobramycin 40 mg/ml Injection JPC Lodalis colesevelane 625 mg VAL ABB APX AUP AUP BUC CIP JPC JPC 1 of 16

3 Mercaptopurine mercaptopurine 50 mg SMI Mint-Pantoprazole pantoprazole 40 mg MPH Mint-Paroxetine Mint-Ramipril NAT-Citalopram paroxetine ramipril citalopram 20 mg 30 mg 2.5 mg 5 mg 15 mg 20 mg 40 mg Capsule Ondansetron ondansetron 4 mg SAH 8 mg pms-atorvastatin atorvastatin PMS pms-levocarb CR levodopa/carbidopa 100/25 mg PMS 200/50 mg pms-methylphenidate ER Reclipsen 21 Reclipsen 28 methylphenidate 18 mg 27 mg 36 mg 54 mg MPH MPH NAT PMS desogestrel/ethinyl estradiol 0.15 mg/0.03 mg ACV Salbutamol HFA salbutamol 100 mcg/dose Metered Dose Inhaler SAH Sandoz Candesartan candesartan 32 mg SDZ Teva-Exemestane exemestane 25 mg TEV Tricira Lo 21 Tricira Lo 28 norgestimate/ethinyl estradiol 0.18/0.025 mg 0.215/0.025 mg 0.25/0.025 mg Vancomycin vancomycin 500 mg/ml 1 g/ml *Abbreviation of Manufacturers' Names Injection APX SDZ Part 2 Additions Mint-Zolmitriptan zolmitriptan 2.5 mg MPH Mint-Zolmitriptan OD zolmitriptan 2.5 mg MPH For the treatment of ACUTE migraine attacks in patients where standard therapy has failed. 2 of 16

4 Montelukast montelukast ACH (a) Indicated as adjunctive therapy for asthma in cases where: (i) maximum doses inhaled corticosteroids have not effectively controlled symptoms, or (ii) evidence of serious adverse effects associated with corticosteroids exists, eg. adrenal suppression, increased lung infections; (b) Indicated as first line therapy for exercise induced asthma. Part 3 Additions The following products will be considered for Pharmacare reimbursement upon an individual prescriber/patient request basis Afinitor everolimus 2.5 mg 5 mg For the treatment of: (a) Advanced Breast Cancer; (b) Advanced or Metastatic Pancreatic Neuroendocrine Tumors (pnet); (c) Advanced/Metastatic Renal Cell Carcinoma (RCC). NVT Alendronate alendronate 5 mg 70 mg As per Fosamax criteria ( ACH CO Imatinib imatinib 100 mg 400 mg Criteria may be obtained from the EDS office at Manitoba Health. ACV Dificid fidaxomicin 200 mg CPC For the treatment of patients: (a) in place of vancomycin if there is a documented allergy to vancomycin; or (b) as an alternative to vancomycin if a patient experiences a severe adverse reaction to vancomycin therapy; or (c) treatment that results in the discontinuation of vancomycin; (d) as an alternative to vancomycin if a patient experiences a 'severe intolerance' to vancomycin treatmen that results in the discontinuation of vancomycin therapy; or (e) for use in the event of vancomycin treatment failure Donepezil donepezil 5 mg Donepezil donepezil 5 mg Mylan-Donepezil donepezil 5 mg As per Aricept criteria ( SIP ACH MYL 3 of 16

5 Fondaparinux fondaparinux sodium 2.5 mg/0.5 ml Injection DRL 7.5 mg/0.6 ml For the prophylaxis of venous thromboembolic events (VTE) in orthopaedic surgery of the lower limbs Fycompa perampanel 2 mg 4 mg 6 mg 8 mg 12 mg EIS For use as an adjunctive therapy in patients in the management ofrefractory partial-onset seizures (POS) in adult patients with epilepsy who are not satisfactorily controlled with conventional therapy and who meet all of the following criteria: (a) are under the care of a physician experienced in the treatment of epilepsy, (b) are currently receiving two or more antiepileptic drugs, and (c) in whom all other antiepileptic drugs are ineffective or not appropriate Mycophenolate mycophenolate mofetil 250 mg 500 mg As per Cellcept criteria ( Capsule ACH Pioglitazone pioglitazone 15 mg 30 mg 45 mg As per Actos criteria ( ACH Tecfidera dimethyl fumarate 120 mg Capsule BIG 240 mg For the treatment of patients 18 years or older who have relapsing-remitting MS when prescribed by a neurologist from the Manitoba MS Clinic Zoledronic Acid zoledronic acid 5 mg/100 ml Injection TEV As per Aclasta criteria ( New Interchangeable Categories The following new interchangeable categories and products were added: Generic Name - Strength - Form DIN Trade Name Manufacturer Fondaparinux mg/0.5 ml - Injection Arixtra GSK Fondaparinux DRL Price in Dollars $ per ml of 16

6 Fondaparinux mg/0.6 ml - Injection Arixtra GSK Fondaparinux DRL $ per ml Haloperidol - 5 mg/ml - Injection $ Haloperidol SDZ Haloperidol OMA Levodopa/Carbidopa - 100/25 mg - s $ Sinemet CR MFX pms-levocarb CR PMS Mercaptopurine - 50 mg - s $ Purinethol TEV Mercaptopurine SMI Norgestimate/Ethinyl Estradiol /0.025 mg, 0.215/0.025 mg, 0.250/0.025 mg - s $ Tri-Cyclen Lo 21 JAN Tricira Lo 21 APX Norgestimate/Ethinyl Estradiol /0.025 mg, 0.215/0.025 mg, 0.250/0.025 mg - s $ Tri-Cyclen Lo 28 JAN Tricira Lo 28 APX Temozolomide - 5 mg - Capsules $ Temodal SCH Apo-Temozolomide APX Temozolomide mg - Capsules $ Temodal SCH Apo-Temozolomide APX Zoledronic Acid - 5 mg/100 ml - Injection Aclasta NVT Zoledronic Acid TEV $ per ml New Interchangeable Products The following products have been added to existing interchangeable drug categories: Alendronate - 5 mg - s $ Alendronate ACH Alendronate - - s $ Alendronate ACH Alendronate - 70 mg - s $ Alendronate ACH of 16

7 Anastrozole - 1 mg - s $ Anastrozole ACH Candesartan - 32 mg - s $ Sandoz Candesartan SDZ Citalopram - - s $ Abbott-Citalopram ABB NAT-Citalopram NAT Citalopram - 20 mg - s $ Abbott-Citalopram ABB NAT-Citalopram NAT Citalopram - 40 mg - s $ Abbott-Citalopram ABB NAT-Citalopram NAT Clopidogrel - 75 mg - s $ Abbott-Clopidogrel ABB Desogestrel/Ethinyl Estradiol /0.03 mg - s $ Reclipsen 21 ACV Desogestrel/Ethinyl Estradiol /0.03 mg - s $ Reclipsen 28 ACV Donepezil - 5 mg - s $ Donepezil ACH Donepezil SIP Mylan-Donepezil MYL Donepezil - - s $ Donepezil ACH Donepezil SIP Mylan-Donepezil MYL Exemestane - 25 mg - s $ Teva-Exemestane TEV Apo-Exemestane APX ** Fluoxetine - - Capsules $ Fluoxetine ACH Fluoxetine - 20 mg - Capsules $ Fluoxetine ACH Imatinib mg - s $ CO Imatinib ACV ** of 16

8 Imatinib mg - s $ CO Imatinib ACV Irbesartan - 75 mg - s $ Jamp-Irbesartan JPC Irbesartan mg - s $ Jamp-Irbesartan JPC Irbesartan mg - s $ Jamp-Irbesartan JPC Irbesartan/Hydrochlorothiazide - 150/12.5 mg - s $ Jamp-Irbesartan/HCTZ JPC Irbesartan/Hydrochlorothiazide - 300/12.5 mg - s $ Jamp-Irbesartan/HCTZ JPC Irbesartan/Hydrochlorothiazide - 300/25 mg - s $ Jamp-Irbesartan/HCTZ JPC Levodopa/Carbidopa - 200/50 mg - s $ pms-levocarb CR PMS ** Methylphenidate - 18 mg - s $ pms-methylphenidate ER PMS Methylphenidate - 27 mg - s $ pms-methylphenidate ER PMS Methylphenidate - 36 mg - s $ pms-methylphenidate ER PMS Methylphenidate - 54 mg - s $ pms-methylphenidate ER PMS Mirtazapine - 15 mg - s $ Auro-Mirtazapine AUP Mirtazapine - 30 mg - s $ Auro-Mirtazapine AUP Montelukast - - s $ Montelukast ACH Mycophenolate mg - s $ Mycophenolate ACH Mycophenolate mg - s $ Mycophenolate ACH of 16

9 Omeprazole - 20 mg - s $ Jamp-Omeprazole DR JPC Ondansetron - 4 mg - s $ Ondansetron SAH Ondansetron - 8 mg - s $ Ondansetron SAH Pantoprazole - 20 mg - s $ Jamp-Pantoprazole JPC Pantoprazole - 40 mg - s $ Jamp-Pantoprazole JPC Mint-Pantoprazole MPH Paroxetine - - s $ Mint-Paroxetine MPH Paroxetine - 20 mg - s $ Mint-Paroxetine MPH Paroxetine - 30 mg - s $ Mint-Paroxetine MPH Pioglitazone - 15 mg - s $ Pioglitazone ACH Pioglitazone - 30 mg - s $ Pioglitazone ACH Pioglitazone - 45 mg - s $ Pioglitazone ACH Ramipril mg - Capsules $ Mint-Ramipril MPH Ramipril - 5 mg - Capsules $ Mint-Ramipril MPH Ramipril - - Capsules $ Mint-Ramipril MPH Ramipril - 15 mg - Capsules $ Mint-Ramipril MPH Salbutamol mcg/dose - Metered Dose Inhaler $ Salbutamol HFA SAH Temozolomide - 20 mg - Capsules $ Apo-Temozolomide APX ** of 16

10 Temozolomide mg - Capsules $ Apo-Temozolomide APX ** Temozolomide mg - Capsules $ Apo-Temozolomide APX ** Tobramycin - 40 mg/ml - Injection Jamp-Tobramycin JPC $ per ml Topiramate - 25 mg - s $ Abbott-Topiramate ABB ** Topiramate mg - s $ Abbott-Topiramate ABB ** Topiramate mg - s $ Abbott-Topiramate ABB ** Valsartan/Hydrochlorothiazide - 80/12.5 mg - s $ Auro-Valsartan HCT AUP Valsartan/Hydrochlorothiazide - 160/12.5 mg - s $ Auro-Valsartan HCT AUP Valsartan/Hydrochlorothiazide - 160/25 mg - s $ Auro-Valsartan HCT AUP Valsartan/Hydrochlorothiazide - 320/12.5 mg - s $ Auro-Valsartan HCT AUP Valsartan/Hydrochlorothiazide - 320/25 mg - s $ Auro-Valsartan HCT AUP Zolmitriptan mg - s $ Mint-Zolmitriptan MPH Zolmitriptan mg - Orally Disintigrating s $ Mint-Zolmitriptan MPH ** The price has resulted in a change to the lowest price in the category. The following products have been deleted Anzemet dolasetron 100 mg s Didrocal Product Deletions etidronate disodium/ calcium carbonate 400/500 mg s 9 of 16

11 Diopred prednisolone 1% Ophthalmic Kytril granisetron 1 mg s Lasix furosemide 20 mg s Lasix furosemide 40 mg s Monopril fosinopril s Monopril fosinopril 20 mg s Naprosyn naproxen 25 mg/ml Suspension Novo-Cimetidine cimetidine 300 mg s Novo-Cimetidine cimetidine 400 mg s Novo-Cimetidine cimetidine 600 mg s Optomyxin Plus gramacidin/neomycin/ polymyxin - Ophthalmic/Otic pms-ciprofloxacin ciprofloxacin 0.3% Ophthalmic pms-levobunolol levobunolol 0.5% Ophthalmic Rhotral acebutolol 100 mg s Rhotral acebutolol 200 mg s Rhotral acebutolol 400 mg s Sandoz Acebutolol acebutolol 100 mg s Sandoz Acebutolol acebutolol 200 mg s Sandoz Acebutolol acebutolol 400 mg s Sandoz Alendronate alendronate 5 mg s Sandoz Anuzinc HC Plus pramoxine/hydrocortisone/ zinc /5 mg/ 5 mg per g Ointment Sandoz Atenolol atenolol 100 mg s Sandoz Atenolol atenolol 50 mg s Sandoz Cefprozil cefprozil 125 mg/5 ml Suspension Sandoz Cefprozil cefprozil 250 mg/5 ml Suspension Sandoz Opticort framycetin/gramicidin/ dexamethasone 0.5 mg/ml Ophthalmic Sandoz Pentasone betamethason/gentamycin 3 mg/ml Ophthalmic Sandoz Ticlopidine ticlopidine 250 mg s Sandoz Zopiclone zopiclone 7.5 mg s Sodium Sulamyd sulfacetamide 10% Ophthalmic - Cabergoline mg - s - Deferoxamine mg - Powder for Injection - Diflunisal mg - s Category Deletions 10 of 16

12 - Docusate Sodium mg - Capsules - Doxepin - - Capsules - Doxepin - 25 mg - Capsules - Doxepin - 50 mg - Capsules - Doxepine - 75 mg - Capsules - Doxepin mg - Capsules - Doxepin mg - Capsules - Fenofibrate - 67 mg - Capsules - Hydrocortisone mg/60 ml - Enema - Nitrazepam - 5 mg - s - Nitrazepam - - s - Polymycin/Neomycin/Hydrocortisone - 10,000 U/3.5 mg//ml - Otic - Testosterone mg/ml - Injection - Trifluridine - 1% - Ophthalmic - Valacyclovir mg - s - Valproic Acid - 50 mg/ml - Syrup - Vancomycin mg/vial - Injection - Vancomycin - 1 g/vial - Injection Interchangeable Product Price Changes The following changes in prices have occurred: ($) Apo-Cefprozil cefprozil 125 mg/5 ml Oral Suspension ** Apo-Cefprozil cefprozil 250 mg/5 ml Oral Suspension ** Apo-Cimtidine cimetidine 300 mg Apo-Cimtidine cimetidine 400 mg Apo-Cimtidine cimetidine 600 mg Apo-Lithium Carbonate lithium carbonate 150 mg Capsule ** Apo-Lithium Carbonate lithium carbonate 300 mg Capsule ** Apo-Ofloxacin ofloxacin 0.3% Ophthalmic CO Raloxifene raloxifene 60 mg Ipravent ipratropium bromide 0.6% Nasal Spray Keppra levetiracetam 250 mg Keppra levetiracetam 500 mg Keppra levetiracetam 750 mg Ketorolac ketorolac Ketorolac ketorolac 0.5% Ophthalmic Novo-Mycophenolate mycophenolate 250 mg Novo-Mycophenolate mycophenolate 500 mg pms-amlodipine/ Atorvastatin amlodipine/atorvastatin 10/ of 16

13 pms-amlodipine/ Atorvastatin amlodipine/atorvastatin 10/20 mg pms-amlodipine/ Atorvastatin amlodipine/atorvastatin 5/ pms-amlodipine/ Atorvastatin amlodipine/atorvastatin 5/20 mg pms-azithromycin azithromycin 250 mg pms-candesartan/ HCTZ candesartan/hctz 16/12.5 mg pms-irbesartan irbesartan 75 mg ** pms-irbesartan irbesartan 150 mg pms-irbesartan irbesartan 300 mg pms-irbesartan/hctz irbesartan/hctz 150/12.5 mg ** pms-irbesartan/hctz irbesartan/hctz 300/12.5 mg pms-paroxetine paroxetine pms-paroxetine paroxetine 20 mg pms-paroxetine paroxetine 30 mg pms-valsartan valsartan 40 mg Prozac fluoxetine Prozac fluoxetine 20 mg Ran-Cefprozil cefprozil 125 mg/5 ml Oral Suspension ** Ran-Cefprozil cefprozil 250 mg/5 ml Oral Suspension ** ratio-alendronate alendronate 70 mg ratio-azithromycin azithromycin 250 mg ratio-bisacodyl bisacodyl ratio-cefuroxime cefuroxime 250 mg ratio-cefuroxime cefuroxime 500 mg ratio-domperidone domperidone ratio-fentanyl fentanyl 12 mcg/h Patch ratio-fentanyl fentanyl 25 mcg/h Patch ratio-fentanyl fentanyl 50 mcg/h Patch ratio-fentanyl fentanyl 75 mcg/h Patch ratio-fentanyl fentanyl 100 mcg/h Patch ratio-gabapentin gabapentin 100 mg ratio-gabapentin gabapentin 300 mg ratio-gabapentin gabapentin 400 mg ratio-irbesartan irbesartan 150 mg ratio-irbesartan irbesartan 75 mg ratio-irbesartan irbesartan 300 mg ratio-irbesartan/hctz irbesartan/hctz 150/12.5 mg ratio-irbesartan/hctz irbesartan/hctz 300/12.5 mg ratio-metformin metformin 500 mg ratio-metformin metformin 850 mg of 16

14 ratio-ondansetron ondansetron 4 mg ratio-ondansetron ondansetron 8 mg ratio-paroxetine paroxetine ratio-paroxetine paroxetine 20 mg ratio-paroxetine paroxetine 30 mg ratio-quetiapine quetiapine 200 mg ratio-sertraline sertraline 25 mg Capsule ratio-sertraline sertraline 50 mg Capsule ratio-sertraline sertraline 100 mg Capsule ratio-zopiclone zopiclone 5 mg Sandoz Azithromycin azithromycin 250 mg Sandoz Candesartan Plus candesartan/hctz 16/12.5 mg Sandoz Irbesartan irbesartan 150 mg Sandoz Irbesartan irbesartan 300 mg Sandoz Irbesartan irbesartan 75 mg Sandoz Irbesartan HCT irbesartan/hctz 150/12.5 mg Sandoz Irbesartan HCT irbesartan/hctz 300/12.5 mg Sandoz Lansoprazole lansoprazole 15 mg Capsule Sandoz Lansoprazole lansoprazole 30 mg Capsule Sandoz Losartan losartan 100 mg Sandoz Losartan losartan 25 mg Sandoz Losartan losartan 50 mg Sandoz Mycophenolate mycophenolate 500 mg Sandoz Mycophenolate mycophenolate 250 mg Capsule Sandoz Paroxetine paroxetine Sandoz Paroxetine paroxetine 20 mg Sandoz Paroxetine paroxetine 30 mg Sandoz Valsartan valsartan 40 mg Sandoz Valsartan HCT valsartan/hctz 160/12.5 mg Sandoz Valsartan HCT valsartan/hctz 160/25 mg Sandoz Valsartan HCT valsartan/hctz 320/12.5 mg Sandoz Valsartan HCT valsartan/hctz 320/25 mg Sandoz Valsartan HCT valsartan/hctz 80/12.5 mg Tetrabenazine tetrabenazine 25 mg Teva-Azithromycin azithromycin 250 mg Teva-Candesartan candesartan 8 mg Teva-Candesartan candesartan 16 mg Teva- Candesartan/HCTZ candesartan/hctz 16/12.5 mg Teva-Domperidone domperidone Teva-Donepezil donepezil 5 mg Teva-Donepezil donepezil Teva-Efavirenz efavirenz 600 mg Teva-Enalapril/HCTZ enalapril/hctz 5/12.5 mg Teva-Enalapril/HCTZ enalapril/hctz 10/25 mg Teva-Gabapentin gabapentin 100 mg Teva-Gabapentin gabapentin 300 mg of 16

15 Teva-Gabapentin gabapentin 400 mg Teva-Galantamine ER galantamine 8 mg Teva-Galantamine ER galantamine 16 mg Teva-Galantamine ER galantamine 32 mg Teva-Hydromorphone hydromorphone 1 mg Teva-Hydromorphone hydromorphone 2 mg Teva-Imatinib imatinib 100 mg Teva-Imatinib imatinib 400 mg Teva-Irbesartan irbesartan 150 mg Teva-Irbesartan irbesartan 75 mg Teva-Irbesartan irbesartan 300 mg Teva-Irbesartan/HCTZ irbesartan/hctz 150/12.5 mg Teva-Irbesartan/HCTZ irbesartan/hctz 300/12.5 mg Teva- Lamivudine/Zidovudine lamivudine/zidovudine 150/300 mg Teva-Lansoprazole lansoprazole 15 mg Teva-Lansoprazole lansoprazole 30 mg Teva-Letrozole letrozole 2.5 mg Teva-Letrozole letrozole 2.5 mg Teva-Losartan losartan 25 mg Teva-Losartan losartan 50 mg Teva-Losartan losartan 100 mg Teva-Metformin metformin 500 mg Teva-Metformin metformin 850 mg Teva-Montelukast montelukast 4 mg Teva-Nevirapine nevirapine 200 mg Teva-Ondansetron ondansetron 4 mg Teva-Ondansetron ondansetron 8 mg Teva-Paroxetine paroxetine Teva-Paroxetine paroxetine 20 mg Teva-Paroxetine paroxetine 30 mg Teva-Quetiapine quetiapine 200 mg Teva-Raloxifene raloxifene 60 mg Teva-Risedronate risedronate 35 mg Teva-Risperidone risperidone 3 mg Teva-Salbutamol HFA salbutamol 100 mcg/dose Inhaler Teva-Sertraline sertraline 25 mg Capsule Teva-Sertraline sertraline 50 mg Capsule Teva-Sertraline sertraline 100 mg Capsule Teva-Telmisartan telmisartan 40 mg Teva-Telmisartan telmisartan 80 mg Teva- Telmisartan/HCTZ telmisartan/hctz 80/12.5 mg Teva- Telmisartan/HCTZ telmisartan/hctz 80/25 mg Teva-Tamsulosin CR tamsulosin 0.4 mg Capsules Teva-Valsartan valsartan 40 mg Teva-Valsartan valsartan 80 mg Teva-Valsartan valsartan 160 mg Teva-Valsartan valsartan 320 mg Teva-Valsartan/HCTZ valsartan/hctz 80/12.5 mg Teva-Valsartan/HCTZ valsartan/hctz 160/12.5 mg of 16

16 Teva-Valsartan/HCTZ valsartan/hctz 160/25 mg Teva-Valsartan/HCTZ valsartan/hctz 320/12.5 mg Teva-Valsartan/HCTZ valsartan/hctz 320/25 mg Teva-Zopiclone zopiclone 5 mg Theo ER theophylline 400 mg ** Theo ER theophylline 600 mg ** Uniphyl theophylline 400 mg ** Uniphyl theophylline 600 mg ** ** The price change has resulted in a change to the lowest price in the category. Discontinued Products The following products will be deleted with the next Formulary amendments Apo-Nitrazepam nitrazepam 5 mg s Apo-Nitrazepam nitrazepam s Auro-Cefprozil cefprozil 125 mg/5 ml Suspension Auro-Cefprozil cefprozil 250 mg/5 ml Suspension Niacin nicotinic acid 500 mg s Sandoz Nitrazepam nitrazepam 5 mg s Sandoz Nitrazepam nitrazepam s Sandoz Pindolol pindolol s Sandoz Pindolol pindolol 5 mg s Manufacturer Updates The following product has had a name and manufacturer change: Solystat (was: pms-sodium polystyrene sulfate) sodium polystrene sulfonate 1 meq/g PPI The following product has had a name and manufacturer change: Apo-Levocarb CR (was: Levocarb CR) levodopa/carbidopa 100 mg/25 mg 200 mg/50 mg APX The following product has had a name change: Teva-Pravastatin (was: Novo-Pravastatin) pravastatin 20 mg 40 mg TEV 15 of 16

17 The following product has had a name change: ACT Amlodipine (was: CO Amlodipine) ACT Atorvastatin (was: CO Atorvastatin) ACT Irbesartan (was: CO Irbesartan) ACT-Pramipexole (was: CO Pramipexole) ACT-Ropinirole (was: CO Ropinirole) ACT Telmisartan (was: CO Telmisartan) ACT Valsartan (was: CO Valsartan) amlodipine atorvastatin irbesartan pramipexole ropinirole telmisartan valsartan 5 mg 20 mg 40 mg 80 mg 75 mg 150 mg 300 mg 0.25 mg 0.5 mg 1 mg 1.5 mg 0.25 mg 1 mg 2 mg 5 mg 40 mg 80 mg 40 mg 80 mg 160 mg 320 mg ACV ACV ACV ACV ACV ACV ACV 16 of 16

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015

BULLETIN # 84. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 22, 2015 BULLETIN # 84 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 22, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014

BULLETIN # 79. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 16, 2014 BULLETIN # 79 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 16, 2014 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013

BULLETIN # 74. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 17, 2013 BULLETIN # 74 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016

BULLETIN # 89. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 20, 2016 BULLETIN # 89 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 20, 2016 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013

BULLETIN # 72. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 18, 2013 BULLETIN # 72 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 18, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013

BULLETIN # 73. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on July 17, 2013 BULLETIN # 73 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on July 17, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013

BULLETIN # 70. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 21, 2013 BULLETIN # 70 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 21, 2013 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006.

BULLETIN # 50. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on March 13, 2006. BULLETIN # 50 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on March 13, 2006. The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - July 2014 Effective July 30, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...

More information

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs

A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS. Pan-Canadian Select Molecule Price Initiative for Generic Drugs Pharmacy Benefact A BULLETIN FOR PHARMACY SERVICE PROVIDERS FROM ALBERTA BLUE CROSS Number 723 February 2018 Pan-Canadian Select Molecule Price Initiative for Generic Drugs Alberta Drug Benefit List prices

More information

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010.

BULLETIN # 65. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 14, 2010. BULLETIN # 65 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 14, 2010. The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017

BULLETIN # 90. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 25, 2017 BULLETIN # 90 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 25, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015

BULLETIN # 80. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 19, 2015 BULLETIN # 80 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 19, 2015 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) Fax / Téléc : (902) DRAFT To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Faye Campbell Manager, PEI Drug Programs Date : December 7, 2009 Tel / Tél : (902) 368-6338 Fax / Téléc : (902) 368-4905 Subject

More information

DT Description Price Category Price change

DT Description Price Category Price change Tariff T Watch October 2014 Readers are no doubt aware of this quarter's bad news for primary care prescribing allocations: NHS England has d the remuneration mechanism for community pharmacies gaining

More information

NBPDP Formulary Update

NBPDP Formulary Update Bulletin # 830 April 4, 2012 NBPDP Formulary Update Please find attached lists of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary and non-listed products subject

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M % June 2016 On 13th May, the DH announced that there would be reductions to Category M prices from June until September. http://psnc.org.uk/our-news/contractor-notice-category-m-price-reduction/ This has

More information

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018

BULLETIN # 101. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on October 18, 2018 BULLETIN # 101 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on October 18, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes December 2013 Effective January 03, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

BULLETIN # 91. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 20, 2017

BULLETIN # 91. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 20, 2017 BULLETIN # 91 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 20, 2017 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN. Update to the 60th Edition of the Saskatchewan Formulary Saskatchewan Ministry of Health July 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #124 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

More information

Ontario Drug Benefit Formulary/ Comparative Drug Index

Ontario Drug Benefit Formulary/ Comparative Drug Index Ontario Drug Benefit Formulary/ Comparative Drug Index Edition 42 Summary of Changes March 2014 Effective March 27, 2014 Ministry of Health and Long-Term Care Table of Contents Additions to Formulary...

More information

BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019

BULLETIN # 102. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on January 24, 2019 BULLETIN # 102 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on January 24, 2019 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M. April 2018 The usual quarterly of Category M prices Another set of similar comments as I made in January: significant increases in many lines which have been subject to price concessions but even more

More information

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018

BULLETIN # 98. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on April 19, 2018 BULLETIN # 98 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on April 19, 2018 The amended Manitoba Specified Drug Regulation and Drug Interchangeability

More information

ANNOUNCEMENT. Dear Valued Customer:

ANNOUNCEMENT. Dear Valued Customer: ANNOUNCEMENT Dear Valued Customer: This is to notify you that Ranbaxy Canada s products will not be currently distributed to you through Kohl and Frisch; however Kohl and Frisch will continue their support

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2016 Effective July 28, 2016 Drug Programs Policy and Strategy Branch Ontario

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - August 2015 Effective August 26, 2015 Ministry of Health and Long-Term Care Table of Contents New Single Source Products...

More information

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES

UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES UPDATE AF Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective March 26, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)

More information

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M % December 16 No Category M changes so the reductions imposed in May which were only supposed to last until September continue As in November, most changes are Category A lines with a few Category C. Significant

More information

Product Selection Committee / Comité de sélection des produits

Product Selection Committee / Comité de sélection des produits New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B

More information

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES

UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES UPDATE AA Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective September 15, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 3 Off

More information

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply

Riesbeck's Pharmacy Reward Club Generic Medication List February 2018 $4 30 Day Supply Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

Alaska Medicaid 90 Day** Generic Prescription Medication List

Alaska Medicaid 90 Day** Generic Prescription Medication List 1 ACYCLOVIR 200 MG CAPSULE BUPROPION HCL 150 MG TAB ER 24H ACYCLOVIR 200 MG/5ML BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 400 MG TABLET BUPROPION HCL 150 MG TABLET ER ACYCLOVIR 800 MG TABLET BUPROPION HCL

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - December 2014 Effective December 18, 2014 Ministry of Health and Long-Term Care Table of Contents New Multi-Source

More information

Updates to the Alberta Drug Benefit List. Effective November 1, 2018

Updates to the Alberta Drug Benefit List. Effective November 1, 2018 Updates to the Alberta Drug Benefit List Effective November 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes June 2018 Effective June 29, 2018 Drug Programs Policy and Strategy Branch Ontario

More information

Updates to the Alberta Drug Benefit List. Effective August 1, 2014

Updates to the Alberta Drug Benefit List. Effective August 1, 2014 Updates to the Alberta Drug Benefit List Effective August 1, 2014 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - October 2015 Effective October 29, 2015 Drug Program Services Branch/Ontario

More information

DT Description Price Category Price change Percentage

DT Description Price Category Price change Percentage June 2017 A slight inflationary pressure in most CCGs from mainly Category A increases. Significant price increases: Most of low concern although those involving the less frequently used tamoxifen strengths

More information

Updates to the Alberta Drug Benefit List. Effective February 1, 2018

Updates to the Alberta Drug Benefit List. Effective February 1, 2018 Updates to the Alberta Drug Benefit List Effective February 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes December 2018 Effective December 21, 2018 Drug Programs Policy and Strategy Branch

More information

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017

Riesbeck's Pharmacy Reward Club Generic Medication List October 2017 Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Inj 50MG/ML 1 3 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml

More information

New Exception Status Benefits

New Exception Status Benefits JULY 2012 Nova Scotia Formulary Updates New Exception Status Benefits Criteria Update: Xarelto Criteria Update: Sutent New Diabetic Products PRP Non-Insured Products Pharmacare Reimbursement Changes to

More information

Summary of Changes to the Alberta Drug Benefit List

Summary of Changes to the Alberta Drug Benefit List Summary of Changes to the Alberta Drug Benefit List Effective April 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number:

More information

Table 1: Price increases for Brand Name Drugs with Generic Equivalents

Table 1: Price increases for Brand Name Drugs with Generic Equivalents Table 1: Price increases for Brand Name Drugs with Generic Equivalents Brand Name Medication and Dose Total % Change Since 10/2012 ACTOS 15 MG TABLET 6.36 11.03 73.39% ACTOS 30 MG TABLET 9.7 16.80 73.23%

More information

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES

UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES UPDATE AB Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective October 25, 2011 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - November 2014 Effective November 27, 2014 Ministry of Health and Long-Term Care Table of Contents New Single Source

More information

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Ministry of Health Drug Plan and Extended Benefits Branch July 2008 Bulletin #115 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE BULLETIN TO THE 58th EDITION OF THE SASKATCHEWAN FORMULARY

More information

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017

Riesbeck's Pharmacy Reward Club Generic Medication List September 2017 Drug Category Allergy, Cold & Flu Antibiotic Treatments Arthritis & Pain Riesbeck's Benzonatate 100mg cap 14 42 Diphenhydramine HCl Cap 50 MG 30 90 Diphenhydramine HCl Liquid 12.5 MG/5ML 720ml 2160ml Hydroxyzine

More information

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES

UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES UPDATE AJ Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective July 27, 2012 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 5 Off Formulary

More information

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES

UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES UPDATE AU Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective May 31, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Multi-Source Drug(s) 2 Off Formulary Interchangeable Product(s)

More information

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902)

Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) Fax / Téléc : (902) To / Destinataire : All Retail Pharmacists and Staff From / Expéditeur : Patrick Crawford Pharmacy Consultant, PEI Drug Programs Date : September 8, 2009 Tel / Tél : (902) 368-6711 Fax / Téléc : (902)

More information

ADHD STIMULANTS-S(SHC)

ADHD STIMULANTS-S(SHC) Step Therapy Simply Health Care 2014 Formulary ID: 14406 Version: 14 Last Updated: 08/01/2014 ADHD STIMULANTS-S(SHC) Daytrana Focalin Xr Strattera Patient needs to have a paid claim for one Step 1 drug

More information

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Health Drug Plan and Extended Benefits Branch April 2006 Bulletin #106 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY All

More information

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES

UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES UPDATE AX Ontario Drug Benefit Formulary/Comparative Drug Index No. 41 Effective August 29, 2013 SUMMARY OF CHANGES TABLE OF CONTENTS Page New Single Source Drug(s) 2 New Multi-Source Drug(s) 4 Off Formulary

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes April 2018 Effective April 30, 2018 Drug Programs Policy and Strategy Branch Ontario

More information

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5 Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes June 2017 Effective June 29, 2017 Drug Programs Policy and Strategy Branch Ontario

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #915 October 30, 2015 NB Drug Formulary Update Please find attached a list of generic drug product updates for the New Brunswick Drug Formulary. Generic drug product additions New generic products

More information

Archived Content. This content was archived on June 24, 2013.

Archived Content. This content was archived on June 24, 2013. This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after

More information

Updates to the Alberta Health and Wellness Drug Benefit List

Updates to the Alberta Health and Wellness Drug Benefit List Updates to the Alberta Health and Wellness Drug Benefit List Effective May 1, 2012 UPDATES TO THE ALBERTA HEALTH AND WELLNESS DRUG BENEFIT LIST Inquiries should be directed to: Pharmacy Services Alberta

More information

Updates to the Alberta Drug Benefit List. Effective May 1, 2018

Updates to the Alberta Drug Benefit List. Effective May 1, 2018 Updates to the Alberta Drug Benefit List Effective May 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Updates to the Alberta Drug Benefit List. Effective September 1, 2018

Updates to the Alberta Drug Benefit List. Effective September 1, 2018 Updates to the Alberta Drug Benefit List Effective September 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780)

More information

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016

New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March 2016 PAGE 1 OF 6 New Interchangeable Products Approved and Benefit Status Within the Nova Scotia Pharmacare Programs March New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price

More information

BULLETIN # 66. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on November 24, 2011.

BULLETIN # 66. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on November 24, 2011. BULLETIN # 66 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on November 24, 2011. The amended Manitoba Specified Drug Regulation and Drug

More information

NBPDP Formulary Update

NBPDP Formulary Update Bulletin # 880 January 28, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick Prescription Drug Program Formulary. Existing interchangeable

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes September 2017 Effective September 28, 2017 Drug Programs Policy and Strategy Branch

More information

BULLETIN # 52. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on September 14, 2006.

BULLETIN # 52. Manitoba Drug Benefits and Interchangeability Formulary Amendments. The following amendments will take effect on September 14, 2006. BULLETIN # 52 Manitoba Drug Benefits and Interchangeability Formulary Amendments The following amendments will take effect on September 14, 2006. The amended Manitoba Specified Drug Regulation and Drug

More information

NB Drug Plans Formulary Update

NB Drug Plans Formulary Update Bulletin #984 October 31, 2018 NB Drug Formulary Update Drug product updates included in this bulletin: Drug product additions - New generic products will be reimbursed up to the category Maximum Allowable

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes March 2019 Effective March 28, 2019 Drug Programs Policy and Strategy Branch Drugs

More information

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil School Corp Formulary Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 43 Summary of Changes August 2018 Effective August 30, 2018 Drug Programs Policy and Strategy Branch

More information

Professionalism & Service with Great Prices

Professionalism & Service with Great Prices Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate

More information

Innovative Products Available. OTC Products Available

Innovative Products Available. OTC Products Available Innovative Products Benfotiamine film-coated tablets 150 mg Cholecalciferol film-coated tablets 22400 I.U. Diltiazem rectal ointment 2% Agents for Treatment of Hemorrhoids and Fissures Blood and Blood

More information

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary Saskatchewan Ministry of Health November 1, 2010 Drug Plan and Extended Benefits Branch Bulletin #126 ISSN 1923-077X SASKATCHEWAN FORMULARY BULLETIN Update to the 60th Edition of the Saskatchewan Formulary

More information

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil

Amitriptyline Hydrochloride Heart Health & BP Amlodipine Besylate 5mg Norvasc Antibiotics Amoxicillin 500 mg Amoxil Antiviral Acyclovir 400mg Zovirax Asthma Advair Diskus Diskus 250/50 Fluticasone/Salmeterol Asthma Albuterol Sulfate 2.5 mg/3 ml Proventil Arthritis and Pain Allendronate Sodium 70 mg Fosamax Arthritis

More information

Bulletin #36. Manitoba Drug Benefits and Interchangeability Formulary Amendments.

Bulletin #36. Manitoba Drug Benefits and Interchangeability Formulary Amendments. Bulletin #36 Manitoba Drug Benefits and Interchangeability Formulary Amendments Copies of the consolidated regulations for Pharmacare benefits and interchangeable drugs (including the enclosed amendments),

More information

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8

QTY LIMIT COPAY (30 DAY/90 DAY) BENIGN PROSTATIC HYPERPLASIA FINASTERIDE $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 $4/$8 2019 LiveWELL Health Plan PREVENTIVE DRUG LIST - GENERIC Names ( Copay) - ALPHABETICAL by DRUG CATEGORY You should always check with your prescriber and/or pharmacist to determine if these alternatives

More information

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories

Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, 2018 New Categories PAGE 1 OF 7 Nova Scotia Pharmacare Programs Interchangeable Product Updates November 13, New Categories A Maximum Reimbursable Price (MRP) or Pharmacare Reimbursement Price (PRP) has been established for

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes July 2017 Effective July 31, 2017 Drug Programs Policy and Strategy Branch Ontario

More information

Updates to the Alberta Drug Benefit List. Effective July 1, 2017

Updates to the Alberta Drug Benefit List. Effective July 1, 2017 Updates to the Alberta Drug Benefit List Effective July 1, 2017 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Updates to the Alberta Drug Benefit List. Effective July 1, 2018

Updates to the Alberta Drug Benefit List. Effective July 1, 2018 Updates to the Alberta Drug Benefit List Effective July 1, 2018 Inquiries should be directed to: Pharmacy Services Alberta Blue Cross 10009 108 Street NW Edmonton AB T5J 3C5 Telephone Number: (780) 498-8370

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ministry of Health and Long-Term Care Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes October 2017 Effective October 30, 2017 Drug Programs Policy and Strategy Branch

More information

Step Therapy Medications

Step Therapy Medications Step Therapy Medications Step Therapy Group APTIOM Step-2: APTIOM 200 MG TABLET or APTIOM 400 MG TABLET or APTIOM 600 MG TABLET or APTIOM 800 MG TABLET Step 1 Drug(s): Oxcarbazepine immediate-release,

More information

Glossary of Medications

Glossary of Medications CLPNA Medications Administration Module Glossary of Medications Acetaminophen. Acetaminophen is a non-opioid analgesic used to manage mild pain and fever. Acetylsalicylic acid. Acetylsalicylic acid is

More information

Archived Content. This content was archived on June 24, 2013.

Archived Content. This content was archived on June 24, 2013. This content was archived on June 24, 2013. Archived Content Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

Formulary for the JHM Outpatient Medication Assistance Program (OMAP)

Formulary for the JHM Outpatient Medication Assistance Program (OMAP) Note: The JHM Outpatient is a clinic-based program and may only be used by outpatient clinics and JHCP sites approved to participate in the program. To be eligible for OMAP, the patient must not have any

More information

Hundreds of Choices. More Savings Every Day. 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses

Hundreds of Choices. More Savings Every Day. 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses 4$ Hundreds of Choices. More Savings Every Day. $ 8 and $ 12 Generics Also Available. Based on 30-day supply at commonly prescribed doses EFF. DATE 09/2017 List subject to change ALLERGIES, COLD AND FLU

More information

Drug Regimen Optimization

Drug Regimen Optimization Texas Prior Authorization Program Clinical Criteria Drug/Drug Class Clinical Criteria Information Included in this Document Excluding Valsartan / Ramipril Prior authorization criteria logic: a description

More information

Medicines Formulary BNF Section 4 Central Nervous System

Medicines Formulary BNF Section 4 Central Nervous System Medicines BNF Section 4 4.1 Hypnotics and anxiolytics Chloral Hydrate 500mg/5ml Solution Clomethiazole 192mg Capsules Lormetazepam Tablets Melatonin Capsules Nitrazepam Suspension Nitrazepam Tablets Temazepam

More information

Ontario Drug Benefit Formulary/Comparative Drug Index

Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index Edition 42 Summary of Changes - January 2015 Effective January 28, 2015 Ministry of Health and Long-Term Care Table of Contents New Multi-Source Products...

More information

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis

20:00. Blood Formulation, Coagulation and Thrombosis. 20:00 Blood Formulation, Coagulation and Thrombosis Blood Formulation, Coagulation and Thrombosis Blood Formulation, Coagulation and Thrombosis 20:04.04 ANTIANEMIA DRUGS (IRON PREPARATIONS) IRON DEXTRAN COMPLEX 50 MG / ML INJECTION 00002205963 DEXIRON LPI

More information

Product Selection Committee / Comité de sélection des produits

Product Selection Committee / Comité de sélection des produits New Brunswick Pharmaceutical Society and New Brunswick Department of Health Product Selection Committee / Comité de sélection des produits L Ordre des pharmaciens P.O. Box / C.P. 5100, Fredericton NB E3B

More information

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY

SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY Saskatchewan Health Drug Plan and Extended Benefits Branch October 2005 Bulletin #104 ISSN 0708-3246 SASKATCHEWAN FORMULARY COMMITTEE UPDATE BULLETIN TO THE 55th EDITION OF THE SASKATCHEWAN FORMULARY All

More information

Guide to the Modernized Reference Drug Program

Guide to the Modernized Reference Drug Program Guide to the Modernized Reference Drug Program For prescribers and pharmacists Medical Beneficiary and Pharmaceutical Services Division June 1, 2016 Contents 1 Introduction 1 2 About this Guide 2 3 About

More information

Pharmacy Savings Program

Pharmacy Savings Program Pharmacy Savings Program SELECT GENERICS DRUG LIST The Pharmacy Savings Program provides you with savings on select generic medications included on this list. The prices for these select generic medications

More information